In this regard, a short-term (1 wk) CSF-1R inhibition with subsequent brain repopulation during glioma progression led to a significant reduction in tumor volume as quantified by both gadolinium-enhanced MRI and 18F-FET PET. The gene discussed is CSF1R; the disease is glioma.